URMC Launches Clinical Trials to Test Hydroxychloroquine in COVID-19 Patients

URMC researchers are joining a pair of national clinical trials this week that will test whether hydroxychloroquine (HCQ), an FDA-approved anti-malarial drug, can keep COVID-19 patients alive and out of the hospital. The two trials, will enroll 20 hospitalized COVID-19 patients at Strong Memorial Hospital and up to 200 people from the greater Rochester region who are diagnosed with COVID-19, but don ’t need to be hospitalized.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: Source Type: news